Literature DB >> 6606980

Cohort analysis of malignant melanoma in five countries.

D J Venzon, S H Moolgavkar.   

Abstract

Vital statistics data on mortality from malignant melanoma from five countries are simultaneously fit by the method of cohort analysis. After the effects of geographic and temporal trends are removed, the proportion of deaths occurring in the younger age groups is found to be higher in females than in males. Relative increases in mortality rates by birth cohort are approximately equal in different regions and appear to be slowing down in recent years.

Entities:  

Mesh:

Year:  1984        PMID: 6606980     DOI: 10.1093/oxfordjournals.aje.a113726

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

Authors:  G G Giles; B K Armstrong; R C Burton; M P Staples; V J Thursfield
Journal:  BMJ       Date:  1996-05-04

2.  Risk for cutaneous melanoma in recent Connecticut birth cohorts.

Authors:  G C Roush; M J Schymura; T R Holford
Journal:  Am J Public Health       Date:  1985-06       Impact factor: 9.308

3.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

4.  Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration.

Authors:  T M Mack; B Floderus
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

5.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations.

Authors:  G Severi; G G Giles; C Robertson; P Boyle; P Autier
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

6.  Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

Authors:  M Thörn; P Sparén; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.